CD274 and triple-negative breast carcinoma: The authors identified a “high-risk” profile for triple-negative breast cancer (TNBC), characterized by low expression levels of PD-L1 and androgen receptor (AR), alongside high expression levels of epidermal growth factor receptor (EGFR) and Ki67 [62].